News

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.
Rashes are a common side effect of some prostate cancer treatments. Rarely, they may be caused by cancer cells.
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
Real Housewives of Beverly Hills alum Teddi Mellencamp shared more bad news amid her ongoing battle with cancer as doctors ...
Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...
First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations. The FDA has approved the use of Gozellix, a ...
The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune ...
As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical ...
Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...
Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.
A new study published in Life Science Alliance reveals a key genetic connection between cancer susceptibility and tissue ...